These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

728 related articles for article (PubMed ID: 24590287)

  • 61. CALINCA-A Novel Pipeline for the Identification of lncRNAs in Podocyte Disease.
    Talyan S; Filipów S; Ignarski M; Smieszek M; Chen H; Kühne L; Butt L; Göbel H; Hoyer-Allo KJR; Koehler FC; Altmüller J; Brinkkötter P; Schermer B; Benzing T; Kann M; Müller RU; Dieterich C
    Cells; 2021 Mar; 10(3):. PubMed ID: 33804736
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CDK inhibitor p21 is prosurvival in adriamycin-induced podocyte injury, in vitro and in vivo.
    Marshall CB; Krofft RD; Pippin JW; Shankland SJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1140-51. PubMed ID: 20130121
    [TBL] [Abstract][Full Text] [Related]  

  • 63. mTOR-mediated podocyte hypertrophy regulates glomerular integrity in mice and humans.
    Puelles VG; van der Wolde JW; Wanner N; Scheppach MW; Cullen-McEwen LA; Bork T; Lindenmeyer MT; Gernhold L; Wong MN; Braun F; Cohen CD; Kett MM; Kuppe C; Kramann R; Saritas T; van Roeyen CR; Moeller MJ; Tribolet L; Rebello R; Sun YB; Li J; Müller-Newen G; Hughson MD; Hoy WE; Person F; Wiech T; Ricardo SD; Kerr PG; Denton KM; Furic L; Huber TB; Nikolic-Paterson DJ; Bertram JF
    JCI Insight; 2019 Sep; 4(18):. PubMed ID: 31534053
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Endothelial
    Luque Y; Lenoir O; Bonnin P; Hardy L; Chipont A; Placier S; Vandermeersch S; Xu-Dubois YC; Robin B; Lazareth H; Souyri M; Guyonnet L; Baudrie V; Camerer E; Rondeau E; Mesnard L; Tharaux PL
    J Am Soc Nephrol; 2017 Dec; 28(12):3563-3578. PubMed ID: 28928136
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Podocyte-specific deletion of integrin-linked kinase results in severe glomerular basement membrane alterations and progressive glomerulosclerosis.
    El-Aouni C; Herbach N; Blattner SM; Henger A; Rastaldi MP; Jarad G; Miner JH; Moeller MJ; St-Arnaud R; Dedhar S; Holzman LB; Wanke R; Kretzler M
    J Am Soc Nephrol; 2006 May; 17(5):1334-44. PubMed ID: 16611717
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Proteome Analysis of Isolated Podocytes Reveals Stress Responses in Glomerular Sclerosis.
    Koehler S; Kuczkowski A; Kuehne L; Jüngst C; Hoehne M; Grahammer F; Eddy S; Kretzler M; Beck BB; Höhfeld J; Schermer B; Benzing T; Brinkkoetter PT; Rinschen MM
    J Am Soc Nephrol; 2020 Mar; 31(3):544-559. PubMed ID: 32047005
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.
    Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR
    J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Role of Protease-Activated Receptor 2 in Regulating Focal Segmental Glomerulosclerosis.
    Wang Y; He Y; Wang M; Lv P; Liu J; Wang J
    Cell Physiol Biochem; 2017; 41(3):1147-1155. PubMed ID: 28245472
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
    Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L
    FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369
    [TBL] [Abstract][Full Text] [Related]  

  • 70. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis.
    Ge M; Molina J; Ducasa GM; Mallela SK; Varona Santos J; Mitrofanova A; Kim JJ; Liu X; Sloan A; Mendez AJ; Banerjee S; Liu S; Szeto HH; Shin MK; Hoek M; Kopp JB; Fontanesi F; Merscher S; Fornoni A
    Hum Mol Genet; 2021 Apr; 30(3-4):182-197. PubMed ID: 33517446
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Transient receptor potential channel 6 (TRPC6) protects podocytes during complement-mediated glomerular disease.
    Kistler AD; Singh G; Altintas MM; Yu H; Fernandez IC; Gu C; Wilson C; Srivastava SK; Dietrich A; Walz K; Kerjaschki D; Ruiz P; Dryer S; Sever S; Dinda AK; Faul C; Reiser J
    J Biol Chem; 2013 Dec; 288(51):36598-609. PubMed ID: 24194522
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Downregulation of microRNA-30 facilitates podocyte injury and is prevented by glucocorticoids.
    Wu J; Zheng C; Fan Y; Zeng C; Chen Z; Qin W; Zhang C; Zhang W; Wang X; Zhu X; Zhang M; Zen K; Liu Z
    J Am Soc Nephrol; 2014 Jan; 25(1):92-104. PubMed ID: 24029422
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Direct action of endothelin-1 on podocytes promotes diabetic glomerulosclerosis.
    Lenoir O; Milon M; Virsolvy A; Hénique C; Schmitt A; Massé JM; Kotelevtsev Y; Yanagisawa M; Webb DJ; Richard S; Tharaux PL
    J Am Soc Nephrol; 2014 May; 25(5):1050-62. PubMed ID: 24722437
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Intrinsic tumor necrosis factor-α pathway is activated in a subset of patients with focal segmental glomerulosclerosis.
    Chung CF; Kitzler T; Kachurina N; Pessina K; Babayeva S; Bitzan M; Kaskel F; Colmegna I; Alachkar N; Goodyer P; Cybulsky AV; Torban E
    PLoS One; 2019; 14(5):e0216426. PubMed ID: 31095586
    [TBL] [Abstract][Full Text] [Related]  

  • 75. TbetaRI independently activates Smad- and CD2AP-dependent pathways in podocytes.
    Xavier S; Niranjan T; Krick S; Zhang T; Ju W; Shaw AS; Schiffer M; Böttinger EP
    J Am Soc Nephrol; 2009 Oct; 20(10):2127-37. PubMed ID: 19679673
    [TBL] [Abstract][Full Text] [Related]  

  • 76. IGF-binding protein-3 modulates TGF-beta/BMP-signaling in glomerular podocytes.
    Peters I; Tossidou I; Achenbach J; Woroniecki R; Mengel M; Park JK; Paschy M; de Groot K; Haller H; Schiffer M
    J Am Soc Nephrol; 2006 Jun; 17(6):1644-56. PubMed ID: 16672319
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
    Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
    Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Podocyte injury and its consequences.
    Nagata M
    Kidney Int; 2016 Jun; 89(6):1221-30. PubMed ID: 27165817
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of Importin- α -Mediated Nuclear Localization of Dendrin Attenuates Podocyte Loss and Glomerulosclerosis.
    Empitu MA; Kikyo M; Shirata N; Yamada H; Makino SI; Kadariswantiningsih IN; Aizawa M; Patrakka J; Nishimori K; Asanuma K
    J Am Soc Nephrol; 2023 Jul; 34(7):1222-1239. PubMed ID: 37134307
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ARHGEF7 (
    Matsuda J; Maier M; Aoudjit L; Baldwin C; Takano T
    J Am Soc Nephrol; 2020 May; 31(5):996-1008. PubMed ID: 32188698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.